Effects on insulin sensitivity and body composition of combination therapy with growth hormone (GH) and insulin-like growth factor-I (IGF-I) in growth hormone deficient adults with impaired glucose tolerance or diabetes.
Phase of Trial: Phase II
Latest Information Update: 24 Mar 2012
At a glance
- Drugs Somatropin/mecasermin (Primary)
- Indications Diabetes mellitus; Glucose intolerance
- Focus Therapeutic Use
- Acronyms GH-IGF-I
- 24 Mar 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 24 Mar 2012 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 14 Jun 2011 New trial record